Degnan Chris insider trades
Degnan Chris has filed 7 Form 4s with the SEC that we hold, for UroGen Pharma Ltd. (URGN) (Chief Financial Officer) and Galera Therapeutics, Inc. (GRTX) (Chief Financial Officer). Across all of them we count 1 purchase worth $19.6K and 2 sales worth $117.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($80.8K). The largest single trade was a sale of 2,202 shares of UroGen Pharma Ltd. worth $80.8K, dated 2026-10-08. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-02 and the latest 2026-10-09.
UroGen Pharma Ltd. (URGN)
Galera Therapeutics, Inc. (GRTX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-03-13 | P, purchase reported on Form 4 | 10,000 | $19.6K | 2023-03-14 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1741968) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
